Patents by Inventor CLAYTON M. YOUNG

CLAYTON M. YOUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10500404
    Abstract: An adaptable healthcare module that is coupleable to one or more defibrillator devices is disclosed. The adaptable health care module includes a healthcare coupling to assist with treatment and/or monitoring of a patient. The healthcare coupling can be active while decoupling the adaptable healthcare module from a first defibrillator device and coupling to a second defibrillator device. The coupling of the adaptable healthcare module includes a mechanical engagement, between the adaptable healthcare module and the defibrillator device, to retain the adaptable healthcare module to the defibrillator device.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: December 10, 2019
    Assignee: Physio-Control, Inc.
    Inventors: Kenneth J. Peterson, John C. Daynes, Mitchell A. Smith, Moira M. Galvin, David B. Stewart, Jennifer G. Jensen, Matthew L. Bielstein, Cathlene D. Buchanan, Jeffrey S. Edwards, Clayton M. Young, Karen K. Langman, Bethany J. Johnson
  • Patent number: 9492090
    Abstract: The present application concerns detecting catheter proximity to a blood-vessel wall and blood-vessel wall artifacts associated therewith. In one embodiment, a light source, in a catheter, can be used to project light into the blood vessel. An intensity associated with at least one light wavelength that interacted with blood can be measured. Based on the measured intensity, a determination can be made regarding blood-vessel wall artifacts due to the catheter tip proximity to a blood-vessel wall. Feedback can be provided to the clinician in order to assist the clinician in adjusting the catheter to optimize signal quality and minimize artifacts due to the blood-vessel wall.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: November 15, 2016
    Assignee: Edwards Lifesciences Corporation
    Inventors: Zhongping Jian, Clayton M. Young, Feras Hatib
  • Publication number: 20160303389
    Abstract: Technologies and implementations for a universally adaptable module for defibrillator monitors are generally disclosed.
    Type: Application
    Filed: April 18, 2016
    Publication date: October 20, 2016
    Inventors: Kenneth J. PETERSON, John C. DAYNES, Mitchell A. SMITH, Moira M. GALVIN, David B. STEWART, Jennifer G. JENSEN, Matthew L. BIELSTEIN, Cathlene E. BUCHANAN, Jeffery S. EDWARDS, Clayton M. YOUNG, Neil G. MCILVAINE, Karen K. LANGMAN, Bethany J. JOHNSON
  • Publication number: 20130324840
    Abstract: The present application concerns detecting catheter proximity to a blood-vessel wall and blood-vessel wall artifacts associated therewith. In one embodiment, a light source, in a catheter, can be used to project light into the blood vessel. An intensity associated with at least one light wavelength that interacted with blood can be measured. Based on the measured intensity, a determination can be made regarding blood-vessel wall artifacts due to the catheter tip proximity to a blood-vessel wall. Feedback can be provided to the clinician in order to assist the clinician in adjusting the catheter to optimize signal quality and minimize artifacts due to the blood-vessel wall.
    Type: Application
    Filed: October 5, 2011
    Publication date: December 5, 2013
    Inventors: Jian Zhongping, Clayton M. Young, Feras Hatib
  • Publication number: 20130324815
    Abstract: The present application relates to continuous measurement of total hemoglobin (tHb) in whole blood. In one embodiment, different wavelengths are used for normalization of the spectral intensity and calculation of the total hemoglobin. In particular, for normalization, a first wavelength is used wherein the wavelength is substantially insensitive to changes in levels of hemoglobin and oxygen saturation. For calculation of the total hemoglobin, a second wavelength is used. The second wavelength is sensitive to changes in levels of hemoglobin, but substantially insensitive to changes in levels of oxygen saturation. In another embodiment, a continuous measurement can be made using two wavelengths that are both sensitive to oxygen saturation, but they both are equally sensitive. In other words, the normalized intensities associated with the two wavelengths change equal amounts with equal changes in oxygen saturation levels.
    Type: Application
    Filed: October 4, 2011
    Publication date: December 5, 2013
    Applicant: Edwards Lifesciences Corporation
    Inventors: Zhongping Jian, Clayton M. Young, Feras Hatib
  • Publication number: 20130310668
    Abstract: A system for optically measuring blood parameters including a light source and light transmitter for transmitting light to the blood, a light remitter for capturing remitted light, a spectrometer breaking the remitted light into its spectral components and a processor for comparing a morphologically distinct portion of the remitted light to a database of known morphologies. Each of the known morphologies corresponds to a measurement value at least one parameter, such as an analyte. Advantageously, the determined morphologies can uniquely correspond to two or more blood parameters, such as O2Hb and tHb, allowing simultaneous determination of the two parameters.
    Type: Application
    Filed: October 3, 2011
    Publication date: November 21, 2013
    Applicant: Edwards Lifesciences Corporation
    Inventor: CLAYTON M. YOUNG